Danaher (DHR) is a publicly traded Healthcare sector company. As of May 20, 2026, DHR trades at $171.07 with a market cap of $115.98B and a P/E ratio of 32.77. DHR moved +2.50% today. Year to date, DHR is -27.50%; over the trailing twelve months it is -14.95%. Its 52-week range spans $160.93 to $279.90. Analyst consensus is strong buy with an average price target of $230.40. Rallies surfaces DHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes DHR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $171.07 |
| Market Cap | $115.98B |
| P/E Ratio | 32.77 |
| EPS | $5.19 |
| Dividend Yield | 0.40% |
| 52-Week High | $279.90 |
| 52-Week Low | $160.93 |
| Volume | 3.32M |
| Avg Volume | 0 |
| Revenue (TTM) | $24.78B |
| Net Income | $3.69B |
| Gross Margin | 58.94% |
16 analysts cover DHR: 0 strong buy, 14 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $230.40.